General Information of the Protein
Protein ID
PT00877
Protein Name
Inhibitor of nuclear factor kappa-B kinase subunit beta
Secondarily
Protein Name
I-kappa-B kinase 2
Nuclear factor NF-kappa-B inhibitor kinase beta
Serine/threonine protein kinase IKBKB
Gene Name
IKBKB
Secondarily
Gene Name
IKKB
Sequence
MSWSPSLTTQTCGAWEMKERLGTGGFGNVIRWHNQETGEQIAIKQCRQELSPRNRERWCLEIQIMRRLTHPNVVAARDVPEGMQNLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREGAILTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEQRLIHKIIDLGYAKELDQGSLCTSFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSEVDIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKWLQLMLMWHPRQRGTDPTYGPNGCFKALDDILNLKLVHILNMVTGTIHTYPVTEDESLQSLKARIQQDTGIPEEDQELLQEAGLALIPDKPATQCISDGKLNEGHTLDMDLVFLFDNSKITYETQISPRPQPESVSCILQEPKRNLAFFQLRKVWGQVWHSIQTLKEDCNRLQQGQRAAMMNLLRNNSCLSKMKNSMASMSQQLKAKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQAVELCGRENEVKLLVERMMALQTDIVDLQRSPMGRKQGGTLDDLEEQARELYRRLREKPRDQRTEGDSQEMVRLLLQAIQSFEKKVRVIYTQLSKTVVCKQKALELLPKVEEVVSLMNEDEKTVVRLQEKRQKELWNLLKIACSKVRGPVSGSPDSMNASRLSQPGQLMSQPSTASNSLPEPAKKSEELVAEAHNLCTLLENAIQDTVREQDQSFTALDWSWLQTEEEEHSCLEQAS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Enzyme
>
Kinase
>
Protein Kinase
>
Other protein kinase group
Function
Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484, PubMed:30337470). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:9346484, PubMed:20434986, PubMed:20797629, PubMed:21138416). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:9346484, PubMed:20434986, PubMed:20797629, PubMed:21138416). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:9346484, PubMed:20434986, PubMed:20797629, PubMed:21138416). In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:14673179, PubMed:20410276, PubMed:21138416). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs (PubMed:11297557, PubMed:20410276, PubMed:21138416). Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1 (PubMed:19716809, PubMed:17213322). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418).
    Show/Hide
Uniprot ID
Primary ID:
O14920

Secondarily ID:
B4DZ30
B4E0U4
O75327
    Show/Hide
Ensembl ID
ENSG00000104365
HGNC ID
HGNC:5960
Subcellular Location
Cytoplasm
Nucleus
Membrane raft
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000017 , HeLa
Compound ID Compound Name Compound Formula
CP0161707
4-(8-methoxy-5,6-dihydrobenzo[h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C19H18N4O3S
 1
1
IC50 = 420 nM
   TI
   LI
   LO
   TS
CP0316313
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-(dimethylamino)ethyl)benzenesulfonamide
   Show/Hide
C20H23N5O2S2
 1
1
IC50 = 510 nM
   TI
   LI
   LO
   TS
CP0249607
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(3-(dimethylamino)propyl)benzenesulfonamide
   Show/Hide
C21H25N5O2S2
 1
1
IC50 = 620 nM
   TI
   LI
   LO
   TS
CP0315053
4-(4-(4-methoxyphenyl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C17H16N4O3S
 1
1
IC50 = 640 nM
   TI
   LI
   LO
   TS
CP0150390
N-[2-(dimethylamino)ethyl]-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C18H21N5O2S2
 1
1
IC50 = 770 nM
   TI
   LI
   LO
   TS
CP0341679
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C16H14N4O2S2
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0258967
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]-2-thiophen-2-ylacetamide
   Show/Hide
C24H21N5O3S2
 1
1
IC50 = 830 nM
   TI
   LI
   LO
   TS
CP0212053
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]-2-thiophen-3-ylacetamide
   Show/Hide
C24H21N5O3S2
 1
1
IC50 = 970 nM
   TI
   LI
   LO
   TS
CP0353912
N-[3-(dimethylamino)propyl]-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C19H23N5O2S2
 1
1
IC50 = 1060 nM
   TI
   LI
   LO
   TS
CP0240439
3,3-dimethyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)butanamide
   Show/Hide
C24H27N5O3S
 1
1
IC50 = 1360 nM
   TI
   LI
   LO
   TS
CP0315052
4-(5,6-dihydrobenzo[h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C18H16N4O2S
 1
1
IC50 = 1430 nM
   TI
   LI
   LO
   TS
CP0308309
2-methyl-N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]propanamide
   Show/Hide
C22H23N5O3S
 1
1
IC50 = 1460 nM
   TI
   LI
   LO
   TS
CP0308307
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]cyclopentanecarboxamide
   Show/Hide
C24H25N5O3S
 1
1
IC50 = 1570 nM
   TI
   LI
   LO
   TS
CP0071107
2-(4-methoxyphenyl)-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)acetamide
   Show/Hide
C27H25N5O4S
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0293649
4-(4-(thiophen-3-yl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C14H12N4O2S2
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0095541
4-(4-(5-methylthiophen-2-yl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C15H14N4O2S2
 1
1
IC50 = 1710 nM
   TI
   LI
   LO
   TS
CP0165746
2-phenyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)acetamide
   Show/Hide
C26H23N5O3S
 1
1
IC50 = 1790 nM
   TI
   LI
   LO
   TS
CP0158759
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
C18H18N4O3S2
 1
1
IC50 = 1960 nM
   TI
   LI
   LO
   TS
CP0212097
3,3-dimethyl-N-(4-(2-(4-sulfamoylphenylamino)pyrimidin-4-yl)phenyl)butanamide
   Show/Hide
C22H25N5O3S
 1
1
IC50 = 2460 nM
   TI
   LI
   LO
   TS
CP0122518
N-(2-hydroxyethyl)-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C16H16N4O3S2
 1
1
IC50 = 3390 nM
   TI
   LI
   LO
   TS
CP0297470
4-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-d]pyrimidin-2-ylamino)-benzenesulfonamide
   Show/Hide
C19H18N4O2S
 1
1
IC50 = 4060 nM
   TI
   LI
   LO
   TS
CP0302345
2-phenyl-N-(4-(2-(4-sulfamoylphenylamino)pyrimidin-4-yl)phenyl)acetamide
   Show/Hide
C24H21N5O3S
 1
1
IC50 = 4470 nM
   TI
   LI
   LO
   TS
CP0302346
3-methyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)butanamide
   Show/Hide
C23H25N5O3S
 1
1
IC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0071106
N-[4-[2-(4-sulfamoylanilino)pyrimidin-4-yl]phenyl]-2-thiophen-2-ylacetamide
   Show/Hide
C22H19N5O3S2
 1
1
IC50 = 6910 nM
   TI
   LI
   LO
   TS
CP0161708
3-methyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)but-2-enamide
   Show/Hide
C23H23N5O3S
 1
1
IC50 = 8250 nM
   TI
   LI
   LO
   TS
CP0684739
3,4-dichloro-2-ethoxy-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzenesulfonamide
   Show/Hide
C17H26Cl2N2O3S
 2
1
IC50 = 32700 nM
   TI
   LI
   LO
   TS
2
IC50 = 55800 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0004106
(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one
   Show/Hide
C28H26N4O3
 7
1 IC50 = 0.9 nM
2 IC50 = 1 nM
3 IC50 = 207 nM
4 IC50 = 250 nM
5 IC50 = 465 nM
6 IC50 = 771 nM
7 Kd = 31 nM
CP0178008
4-(2-cyclopropyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
C18H19N3O3S
 1
1 IC50 = 7.943 nM
CP0212097
3,3-dimethyl-N-(4-(2-(4-sulfamoylphenylamino)pyrimidin-4-yl)phenyl)butanamide
   Show/Hide
C22H25N5O3S
 1
1 IC50 = 10 nM
CP0210238
N,12-dimethyl-14,15,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1,3,5,7,9,11,13,16-octaen-16-amine
   Show/Hide
C16H14N4
 2
1 IC50 = 10.96 nM
2 IC50 = 11 nM
CP0160132
N,12-dimethyl-11,14,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1,3,5,7,9,12,14,16-octaen-16-amine
   Show/Hide
C16H14N4
 2
1 IC50 = 18 nM
2 IC50 = 18.2 nM
CP0224246
2-({12-methyl-11,14,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1,3,5,7,9,12,14,16-octaen-16-yl}amino)ethan-1-ol
   Show/Hide
C17H16N4O
 2
1 IC50 = 18 nM
2 IC50 = 18.2 nM
CP0095541
4-(4-(5-methylthiophen-2-yl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C15H14N4O2S2
 1
1 IC50 = 19 nM
CP0071106
N-[4-[2-(4-sulfamoylanilino)pyrimidin-4-yl]phenyl]-2-thiophen-2-ylacetamide
   Show/Hide
C22H19N5O3S2
 1
1 IC50 = 20 nM
CP0709611
N-methyl-N'-(1-methyl-3,5,11b-triaza-cyclopenta[a]anthracen-4-yl)-ethane-1,2-diamine hydrochloride
   Show/Hide
C18H20ClN5
 1
1 IC50 = 23 nM
CP0210251
benzopyrazoloquinazoline analogue, 13b
   Show/Hide
C18H19N5
 2
1 IC50 = 34.67 nM
2 IC50 = 35 nM
CP0035693
N-(2-hydroxyethyl)-N-methyl-4-(2-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)benzenesulfonamide
   Show/Hide
C17H19N3O3S
 1
1 IC50 = 39.81 nM
CP0009085
(4-(4-(benzo[b]thiophen-2-yl)pyrimidin-2-ylamino)phenyl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone
   Show/Hide
C28H29N5OS
 3
1 IC50 = 39.81 nM
2 IC50 = 40 nM
3 IC50 = 6460 nM
CP0315053
4-(4-(4-methoxyphenyl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C17H16N4O3S
 1
1 IC50 = 40 nM
CP0133399
12-methyl-N-[2-(piperidin-1-yl)ethyl]-11,14,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1,3,5,7,9,12,14,16-octaen-16-amine
   Show/Hide
C22H25N5
 2
1 IC50 = 45.71 nM
2 IC50 = 46 nM
CP0302345
2-phenyl-N-(4-(2-(4-sulfamoylphenylamino)pyrimidin-4-yl)phenyl)acetamide
   Show/Hide
C24H21N5O3S
 1
1 IC50 = 50 nM
CP0210250
N-(2-aminoethyl)-12-methyl-12,14,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,15}]heptadeca-1,3,5,7,9,11(15),13,16-octaen-16-amine
   Show/Hide
C17H17N5
 1
1 IC50 = 58 nM
CP0015576
N-(6-chloro-9H-pyrido[3,4-b]indol-8-yl)pyridine-3-carboxamide
   Show/Hide
C17H11ClN4O
 3
1 IC50 = 87 nM
2 IC50 = 150 nM
3 IC50 = 250 nM
CP0122518
N-(2-hydroxyethyl)-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C16H16N4O3S2
 1
1 IC50 = 130 nM
CP0353912
N-[3-(dimethylamino)propyl]-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C19H23N5O2S2
 1
1 IC50 = 170 nM
CP0293649
4-(4-(thiophen-3-yl)pyrimidin-2-ylamino)benzenesulfonamide
   Show/Hide
C14H12N4O2S2
 1
1 IC50 = 180 nM
CP0150390
N-[2-(dimethylamino)ethyl]-4-[(4-thiophen-3-ylpyrimidin-2-yl)amino]benzenesulfonamide
   Show/Hide
C18H21N5O2S2
 1
1 IC50 = 230 nM
CP0709373
N1-(1,8-dimethylimidazo[1,2-a]quinoxalin-4-yl)ethane-1,2-diamine hydrochloride
   Show/Hide
C14H18ClN5
 2
1 IC50 = 240 nM
2 IC50 = 300 nM
CP0212053
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]-2-thiophen-3-ylacetamide
   Show/Hide
C24H21N5O3S2
 1
1 IC50 = 310 nM
CP0258967
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]-2-thiophen-2-ylacetamide
   Show/Hide
C24H21N5O3S2
 1
1 IC50 = 510 nM
CP0161707
4-(8-methoxy-5,6-dihydrobenzo[h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C19H18N4O3S
 1
1 IC50 = 550 nM
CP0316313
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-(dimethylamino)ethyl)benzenesulfonamide
   Show/Hide
C20H23N5O2S2
 1
1 IC50 = 770 nM
CP0249607
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(3-(dimethylamino)propyl)benzenesulfonamide
   Show/Hide
C21H25N5O2S2
 1
1 IC50 = 780 nM
CP0341679
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C16H14N4O2S2
 1
1 IC50 = 790 nM
CP0240439
3,3-dimethyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)butanamide
   Show/Hide
C24H27N5O3S
 1
1 IC50 = 820 nM
CP0308309
2-methyl-N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]propanamide
   Show/Hide
C22H23N5O3S
 1
1 IC50 = 1110 nM
CP0158759
4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
C18H18N4O3S2
 1
1 IC50 = 1220 nM
CP0161708
3-methyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)but-2-enamide
   Show/Hide
C23H23N5O3S
 1
1 IC50 = 1590 nM
CP0071107
2-(4-methoxyphenyl)-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)acetamide
   Show/Hide
C27H25N5O4S
 1
1 IC50 = 1830 nM
CP0315052
4-(5,6-dihydrobenzo[h]quinazolin-2-ylamino)benzenesulfonamide
   Show/Hide
C18H16N4O2S
 1
1 IC50 = 1830 nM
CP0302346
3-methyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)butanamide
   Show/Hide
C23H25N5O3S
 1
1 IC50 = 1940 nM
CP0308307
N-[2-(4-sulfamoylanilino)-5,6-dihydrobenzo[h]quinazolin-8-yl]cyclopentanecarboxamide
   Show/Hide
C24H25N5O3S
 1
1 IC50 = 2200 nM
CP0165746
2-phenyl-N-(2-(4-sulfamoylphenylamino)-5,6-dihydrobenzo[h]quinazolin-8-yl)acetamide
   Show/Hide
C26H23N5O3S
 1
1 IC50 = 2380 nM
CP0072339
4-oxo-N-[3-(trifluoromethyl)phenyl]-1,2,5-oxadiazole-3-carboxamide
   Show/Hide
C10H6F3N3O3
 1
1 IC50 > 100000 nM
CP0072340
N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide
   Show/Hide
C15H8ClF6NO2
 1
1 IC50 > 100000 nM
CP0667266
5-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-2H-1,2,3-triazole-4-carboxamide
   Show/Hide
C11H6F6N4O2
 1
1 IC50 > 100000 nM
CP0667659
4-Hydroxy-N-[3-(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide
   Show/Hide
C10H6F3N3O2S
 1
1 IC50 > 100000 nM
CP0670568
3-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1-methyl-1H-pyrazole-4-carboxamide
   Show/Hide
C13H9F6N3O2
 1
1 IC50 > 100000 nM
CP0673028
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-oxadiazole-3-carboxamide
   Show/Hide
C11H5F6N3O3
 1
1 IC50 > 100000 nM
CP0673033
4-Amino-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-oxadiazole-3-carboxamide
   Show/Hide
C11H6F6N4O2
 1
1 IC50 > 100000 nM
CP0673034
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1-methyl-1H-1,2,3-triazole-5-carboxamide
   Show/Hide
C12H8F6N4O2
 1
1 IC50 > 100000 nM
CP0684751
4-Methoxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide
   Show/Hide
C12H7F6N3O2S
 1
1 IC50 > 100000 nM
CP0684752
3-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,5-dimethyl-1H-pyrazole-4-carboxamide
   Show/Hide
C14H11F6N3O2
 1
1 IC50 > 100000 nM
CP0684753
5-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-2-methyl-2H-1,2,3-triazole-4-carboxamide
   Show/Hide
C12H8F6N4O2
 1
1 IC50 > 100000 nM
CP0703209
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide
   Show/Hide
C11H5F6N3O2S
 1
1 IC50 > 100000 nM
Clinical Information about the Protein
Target 1 ( Inhibitor of nuclear factor kappa-B kinase beta (IKKB) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Acne vulgaris [ICD-11: ED80]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 IMD-0354 Phase 1
Acne vulgaris